Finance

Lists
Why is SABSW down 74,42%?
Dive Deeper
SABSW:NASDAQ
SAB Biotherapeutics, Inc.
0,0011 US$
-74,42%
(-0,0032) 1D
22 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SABSW...
Open
0,01 US$
High
0,01 US$
Low
0,00 US$
Mkt. cap
276,60 მლნ.
Avg. vol.
60,22 ათ.
Volume
581,55 ათ.
52-wk high
0,20 US$
52-wk low
0,00 US$
Beta
1,34
No. of employees
86
Open
0,01 US$
High
0,01 US$
Low
0,00 US$
Mkt. cap
276,60 მლნ.
Avg. vol.
60,22 ათ.
Volume
581,55 ათ.
52-wk high
0,20 US$
52-wk low
0,00 US$
Beta
1,34
No. of employees
86
News stories
From web sources and news partners
About SAB Biotherapeutics, Inc.
CEO-
Employees86
Founded2014
Headquartersმაიამი-ბიჩი, ფლორიდა, ამერიკის შეერთებული შტატები
Sector-
Websitesab.bio
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
8,97 მლნ.
9,73 მლნ.
13,40 მლნ.
16,17 მლნ.
Cost of revenue
8,97 მლნ.
9,73 მლნ.
13,40 მლნ.
16,17 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,71 მლნ.
6,04 მლნ.
6,60 მლნ.
7,20 მლნ.
Operating expense
3,71 მლნ.
6,04 მლნ.
6,60 მლნ.
7,20 მლნ.
Total operating expenses
12,68 მლნ.
15,77 მლნ.
20,00 მლნ.
23,38 მლნ.
Operating income
-12,68 მლნ.
-15,77 მლნ.
-20,00 მლნ.
-23,38 მლნ.
Other non operating income
57,51 მლნ.
-1,73 მლნ.
144,40 ათ.
-761,00 ათ.
EBT including unusual items
45,45 მლნ.
-16,86 მლნ.
-18,87 მლნ.
-22,49 მლნ.
EBT excluding unusual items
45,45 მლნ.
-16,86 მლნ.
-18,87 მლნ.
-22,49 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
45,45 მლნ.
-16,86 მლნ.
-18,87 მლნ.
-22,49 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-0,41
-
-0,28
Interest and investment income
655,23 ათ.
700,74 ათ.
1,05 მლნ.
1,71 მლნ.
Interest expense
-43,29 ათ.
-63,46 ათ.
-62,74 ათ.
-62,00 ათ.
Net interest expenses
611,94 ათ.
637,28 ათ.
984,45 ათ.
1,65 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-11,91 მლნ.
-15,01 მლნ.
-19,25 მლნ.
-22,54 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები